Q1 2022 Holdings
Filed 2022-05-16 | 135 holdings | $473.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $113.3M | 5,163,517 | 23.9% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $60.6M | 4,695,848 | 12.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $50.5M | 2,082,723 | 10.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $44.0M | 9,903,879 | 9.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $39.0M | 3,839,380 | 8.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.4M | 180,079 | 6.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $23.9M | 3,188,750 | 5.0% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $21.8M | 11,933,387 | 4.6% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $18.9M | 1,474,107 | 4.0% |
| Artivion Inc(AORT) | COM | 228903100 | $13.2M | 615,703 | 2.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $12.8M | 405,000 | 2.7% |
| CUE Health Inc(HLTHQ) | COM | 229790100 | $10.2M | 1,580,607 | 2.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $10.0M | 1,190,952 | 2.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $6.9M | 284,853 | 1.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $6.6M | 383,239 | 1.4% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $5.3M | 1,500,000 | 1.1% |
| Acumen Pharmaceuticals Inc(ABOS) | COM | 00509G209 | $2.3M | 596,942 | 0.5% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $474.1K | $45,000,000 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $261.0K | 27,555,845 | 0.1% |
| Springworks Therapeutics Inc | COM | 85205L107 | $255.6K | 4,527,993 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $208.9K | 56,319,960 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $203.2K | 12,201,261 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $195.7K | 2,380,710 | 0.0% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $178.4K | 21,294,485 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $178.1K | 5,086,727 | 0.0% |
| Horizon Therapeutics PLC | SHS | G46188101 | $142.9K | 1,357,903 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $134.8K | 3,892,493 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $96.2K | 6,948,277 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $92.2K | 2,440,582 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $89.5K | $9,500,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $87.9K | 5,225,415 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $86.9K | 52,335,002 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $85.5K | 1,883,399 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $75.3K | 1,481,700 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $73.7K | 2,411,447 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $70.4K | 2,360,139 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $61.6K | 2,799,962 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $58.2K | 1,943,097 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $56.0K | 8,136,630 | 0.0% |
| Procept Biorobotics Corp(PRCT) | COM | 74276L105 | $52.1K | 1,488,284 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $47.6K | 1,845,555 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $46.3K | 3,425,916 | 0.0% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $44.6K | $4,500,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $41.5K | 1,655,079 | 0.0% |
| Cincor Pharma Inc | COM | 17240Y109 | $40.7K | 2,319,117 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $39.7K | 1,781,235 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $39.5K | 9,111,151 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $37.1K | 395,639 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $34.9K | 5,325,615 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $34.5K | 477,037 | 0.0% |